Treatment of Base of Tongue Cancer With Paclitaxel, Ifosfamide, and Cisplatinum Induction Chemotherapy Followed by Chemoradiotherapy
暂无分享,去创建一个
[1] A. Cmelak,et al. Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] J. Netterville,et al. Taxane‐based chemoirradiation for organ preservation with locally advanced head and neck cancer: Results of a phase II multi‐institutional trial , 2007, Head & neck.
[3] T. Pajak,et al. Long-term results of Intergroup RTOG 91-11: A phase III trial to preserve the larynx-Induction cisplatin/5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] J. Grandis,et al. Head and neck cancer: recent advances and new standards of care. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] M. Leblanc,et al. Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] G. Weinstein,et al. Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania Phase II Trial. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] K. Ang,et al. Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] W. Hong,et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. , 1991, The New England journal of medicine.